Acta de reunión clínica

← vista completa

Publicado el 1 de noviembre de 2008 | http://doi.org/10.5867/medwave.2008.10.1790

Estrategias actuales para enfrentar el tabaquismo

Current strategies to address smoking

Laura Mendoza

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Laura Mendoza

Hospital Clínico Universidad de Chile, Santiago, Chile

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Mendoza L. Current strategies to address smoking. Medwave 2008;8(10):e1790 doi: 10.5867/medwave.2008.10.1790

Envío 01/01/1970

Aceptación 01/01/1970

Publicación 01/11/2008

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Referencias

  1. Edwards R. The problem of tobacco smoking. BMJ. 2004 Jan 24;328(7433):217-9. | CrossRef | PubMed
  2. Bello S, Soto M, Michalland S, Salinas J. A national survey on smoking habit among health care workers in Chile. Rev Med Chil. 2004 Feb;132(2):223-32. | PubMed
  3. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004 Jun 26;328(7455):1519. Epub 2004 Jun 22. | CrossRef | PubMed
  4. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000165. | PubMed
  5. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001007. | PubMed
  6. Ussher M, Nunciata P, Cropley M, West R. Effect of a short bout of exercise on tobacco withdrawal symptoms and desire to smoke. Psychopharmacology (Berl). 2001 Oct;158(1):66-72. | CrossRef | PubMed
  7. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA. 1994 Feb 23;271(8):595-600. | CrossRef | PubMed
  8. Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther. 2005 Dec;78(6):689-96. | CrossRef | PubMed
  9. Richmond RL, Kehoe L, de Almeida Neto AC. Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioural programme: one year outcome. Addiction. 1997 Jan;92(1):27-31. | PubMed
  10. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2001;(3):CD000146. | PubMed
  11. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4;340(9):685-91. | CrossRef | PubMed
  12. Gold PB, Rubey RN, Harvey RT. Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care. Am J Addict. 2002 Fall;11(4):315-31. Am J Addict. 2002 Fall;11(4):315-31. | CrossRef | PubMed
  13. Swan GE, McAfee T, Curry SJ, Jack LM, Javitz H, Dacey S, et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med. 2003 Oct 27;163(19):2337-44. | CrossRef | PubMed
  14. Chandola T, Head J, Bartley M. Socio-demographic predictors of quitting smoking: how important are household factors? Addiction. 2004 Jun;99(6):770-7. | CrossRef | PubMed
  15. Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of Maintenance Therapy with Varenicline on Smoking Cessation JAMA. 2006 Jul 5;296(1):64-71. | PubMed
  16. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al for the Varenicline Phase 3 Study Group. Efficacy of Varenicline, an alpha4 beta2 Nicotinic Acetylcholine Receptor Partial Agonist versus placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006 Jul 5;296(1):56-63. | CrossRef | PubMed
  17. White A, Resch K, Ernst E. A metanalysis of acupuncture techniques for smoking cessation. Tob Control. 1999 Winter;8(4):393-7. | CrossRef | PubMed